[vc_row][vc_column][vc_row_inner css=”%7B%22default%22%3A%7B%22margin-bottom%22%3A%222rem%22%7D%7D”][vc_column_inner width=”1/2″][vc_column_text]One of the basic requirements of US patents is that they be “enabled”. This “enablement” allows one of ordinary skill in the art to read the patent and be able to make and use the described technology without undue experimentation. Basically, it shouldn’t be too hard to get the invention to work after you read the patent.
美国最高法院最近确认了联邦上诉法院关于安进公司两项专利无效的裁决。 这两项专利通过氨基酸序列明确描述了 26 种抗体，但权利要求涵盖了大量抗体。
The two patents claim antibodies that bind to specific sequences of PCSK9 (a naturally occurring protein) and that block PCSK9 from binding to LDL receptors. The antibodies are useful to treat patients having high LDL cholesterol.[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/2″][us_image image=”315″][/vc_column_inner][/vc_row_inner][vc_column_text]The court found that the enormous number of antibodies covered by the claims’ functional language was simply too much to be enabled by 26 specific antibody sequences.
虽然此案具体涉及专利问题，但 Tangibly 的首席执行官问我，这是否隐含着商业秘密的角度。
在撰写专利申请时，总会遇到一些矛盾。 一方面，专利申请人希望披露尽可能多的细节，以满足授权要求。 另一方面，申请人可能希望对发明的某些方面保密，以进一步在竞争中取得优势。
授权/披露越好，商业秘密就越弱。 同样，商业秘密越强，授权越弱。 与通常的 "专利或商业秘密 "二元论相比，这是一种更细致入微的思维方式。 它几乎就像一个转盘，而不是一个开关。
资料来源
https://www.supremecourt.gov/opinions/22pdf/21-757_k5g1.pdf[/vc_column_text][/vc_column][/vc_row]
